Tag | Content |
---|
EnhancerAtlas ID | HS109-10405 | Organism | Homo sapiens | Tissue/cell | Kasumi-1 | Coordinate | chr18:43249840-43251130 | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_25581 | chr18:43244429-43252364 | DND41 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH18I045668 | chr18 | 43248723 | 43252132 |
| Enhancer Sequence | CATTCAATCA CACGGAATCA TTCAAGTCGT ACACATCATG CTACCATCTA TTGGCTTAAG 60 AAGTCGTTGT TCCAACCTCC AGAGTTTATT CCCTTCACTC ACAAAAGCTG GGCCTGGTGG 120 CACATGCCTA TAGTCCCAGC TACTCAGAAG GCTGAGGTGG GAGGATCGCT TGAGCCCAGG 180 AGTTTGAGGC TGCAGTGCGC TGTGATTGTG TCACTGCACT CCATGAGACT CTATCTCCAA 240 AACAAAAACA AAAACCCCAA AATCAAATCG TTTTCTTGCT AAATACTGGT GCTTCTCAGT 300 GTAAACTCAG GGCTTTTTCT ACTACACCAT GCTGTTGGTT TTAAAGCACA GGTGTTCTTT 360 CATTAAGAAA CATATAACAG AGCTTTTAAA GTTTTTTTTA ATAAGTATTC TGTATATAAT 420 CCTGACCTCT GGAAGTCAGC CAAGGTGATT AATAAGAAGC TGCACTCACA GTATTAAGTC 480 AGCCTAGAGA AATGTGCCTA TTAGCCAGCC ACCTTATCTA ACAAGGCACG TTTTCTCCAA 540 GGCCCTCCTA CTTTCCGTTA CACGAAACGG CTCCACAGTC TGGCGCTCAC TCTGAGACTT 600 CGTTATTGGC AACTCATCAT CTGACCACAA AATCACTTGG GCTTGTTGAA GGAACTTTCT 660 CTAAAATAAT GATGCCTCGT TTCTCTTAGC TTTCCACAGT AAGCAACAGC GTGGTGTAGT 720 AGAAAGAGCC CTGAATTTAC ACTGAGAAGC ACCAGTATTT AGCAAGAAAA CTATTCGATT 780 TTGGGGTTTC TGTTTTTGTT TCAGAGATAG AGTCTCATTC TGTCACCCCG GCTGGAGTGC 840 AGTGACGCAA TCACAGCTCA CTGCAGCCTC AAACTCCTGT GTTCAAGGGA TCCTCCCACC 900 TCAGCCTTCT GAGTAGCTGG GACTACAGTC ATGTGCCACC AGGCCCAGCT AATTCTTTAT 960 ATTTTTTTGT AGAGATCGCT CTTGTCATTG TTGCCCAGGC TGGTCTCAAA CCTCTGGCCT 1020 CAAGCGATCA TGCCACCTCA GCCTCCCAAA GTGCTGGGAT TACAGGCGTG GACCATTACA 1080 CCTGGCTGAG AACTATTTGT GTTAGTCGGA TCCTTGATCA TTTTGTGTGT GTGAGGACCT 1140 TCTTGGACCA GAAACAAGAA AAGGTGCTGT GCTGGCAGTT CAGCTTCTTA AGCTGCCCGT 1200 TCTTAGTCTA CCCAATTAAT ATCTTTTGGA GACAAACTTG CTCTAAGTGG CATGCTATGG 1260 GGAAATGATG TCAGAAAATG CAGATTTTAG 1290
|
| |
|
|
|